Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Communications Earth & Environment|January 1, 2026
Lava effusion in mountainous terrain generates flow backup and excess inundationAnnie Borch, Thomas J Jones, James K Russell
Frontiers in Immunology|October 4, 2021
T Cell Epitope Prediction and Its Application to ImmunotherapyAnna-Lisa Schaap-Johansen, Milena Vujović, Annie Borch, et al.
Cytotherapy|March 24, 2020
Common phenotypic dynamics of tumor-infiltrating lymphocytes across different histologies upon checkpoint inhibition: impact on clinical outcomeVinicius Araujo B de Lima, Annie Borch, Morten Hansen, et al.
Frontiers in Immunology|April 1, 2020
Tumor-Infiltrating T Cells From Clear Cell Renal Cell Carcinoma Patients Recognize Neoepitopes Derived From Point and Frameshift MutationsUlla Kring Hansen, Sofie Ramskov, Anne-Mette Bjerregaard, et al.
Frontiers in Genetics|April 10, 2023
Neoepitope load, T cell signatures and PD-L2 as combined biomarker strategy for response to checkpoint inhibition immunotherapyAnnie Borch, Anne-Mette Bjerregaard, Vinicius Araujo Barbosa de Lima, et al.
Cancer Immunology Research|June 17, 2024
Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint PathwaysSigne K Skadborg, Simone Maarup, Arianna Draghi, et al.
The Journal of Clinical Investigation|November 23, 2021
Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanomaNikolaj Pagh Kristensen, Christina Heeke, Siri A Tvingsholm, et al.
Nature Communications|November 10, 2020
Human endogenous retroviruses form a reservoir of T cell targets in hematological cancersSunil Kumar Saini, Andreas Due Ørskov, Anne-Mette Bjerregaard, et al.
Nature Communications|April 12, 2022
Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinomaJeppe Sejerø Holm, Samuel A Funt, Annie Borch, et al.
Frontiers in Immunology|April 18, 2024
IMPROVE: a feature model to predict neoepitope immunogenicity through broad-scale validation of T-cell recognitionAnnie Borch, Ibel Carri, Birkir Reynisson, et al.
Pageof 2